Invention Application
- Patent Title: Prodrugs of a JAK Inhibitor Compound for Treatment of Gastrointestinal Inflammatory Disease
-
Application No.: US16555222Application Date: 2019-08-29
-
Publication No.: US20190389895A1Publication Date: 2019-12-26
- Inventor: Ryan Hudson , Daniel D. Long , Donna A.A. Wilton , Mandy Loo , Patrick J. Brassil
- Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
- Applicant Address: US CA South San Francisco
- Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07H15/26
- IPC: C07H15/26 ; C12P17/16
Abstract:
The invention provides compounds which are prodrugs of a JAK inhibitor agent for the targeted delivery of the JAK inhibitor to the gastrointestinal tract of a mammal. The invention also provides pharmaceutical compositions comprising the compounds, methods of using the compounds to treat gastrointestinal inflammatory diseases, and processes and intermediates useful for preparing the compounds.
Public/Granted literature
- US10961267B2 Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease Public/Granted day:2021-03-30
Information query
